Testing and Treating Helicobacter pylori Infection in Individuals With Family History of Gastric Cancer is Cost-effective

Gastroenterology. 2021 Dec;161(6):2051-2052.e4. doi: 10.1053/j.gastro.2021.08.042. Epub 2021 Aug 27.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Breath Tests / economics
  • Cost Savings
  • Cost-Benefit Analysis
  • Diagnostic Screening Programs / economics*
  • Drug Costs
  • Female
  • Genetic Predisposition to Disease
  • Health Care Costs*
  • Health Status
  • Helicobacter Infections / diagnosis*
  • Helicobacter Infections / drug therapy*
  • Helicobacter Infections / economics*
  • Helicobacter Infections / microbiology
  • Helicobacter pylori / drug effects*
  • Helicobacter pylori / pathogenicity
  • Heredity
  • Humans
  • Immunologic Tests / economics
  • Male
  • Markov Chains
  • Middle Aged
  • Models, Economic
  • Pedigree
  • Predictive Value of Tests
  • Quality of Life
  • Quality-Adjusted Life Years
  • Risk Assessment
  • Risk Factors
  • Stomach Neoplasms / economics*
  • Stomach Neoplasms / genetics
  • Stomach Neoplasms / microbiology
  • Stomach Neoplasms / prevention & control*
  • Time Factors
  • Treatment Outcome